Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109156) titled 'Testing whether myo-inositol (a nutritional supplement) can reduce diabetes risk in pregnant women' on April 23.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Stratified randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Open Label
Primary Sponsor: Endocrinology Society of India
Intervention:
Intervention1: Tab.Myoinositol: Intervention group -Tab.Myoinositol 2 grams twice a day with Tab.Folic acid 200 mcg twice a day orally from 5 to 12 weeks of g...